Filter
162
Text search:
antipsychotic
Featured
Recommendations
29
New Publications
24
Language
Document type
No document type
120
Guidelines
16
Manuals
11
Studies & Reports
7
Fact sheets
4
Training Material
2
Brochures
1
Resource Platforms
1
Countries / Regions
Ethiopia
8
South Africa
4
Global
4
India
3
Western and Central Europe
3
Eastern Europe
3
Zimbabwe
2
Nepal
2
Kenya
2
Jamaica
2
Sierra Leone
1
Nigeria
1
Ghana
1
South Sudan
1
Afghanistan
1
Zambia
1
Syria
1
Bangladesh
1
Brazil
1
Ukraine
1
Botswana
1
Latin America and the Carribbean
1
Eastern Europe and Central Asia
1
Paraguay
1
Asia
1
Venezuela
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
28
Clinical Guidelines
8
Public Health
6
Capacity Building
1
Key Resources
1
Pharmacy & Technologies
1
Toolboxes
Mental Health
122
Pharmacy
8
COVID-19
3
NCDs
3
Conflict
2
TB
2
Global Health Education
2
Planetary Health
2
Disability
1
Natural Hazards
1
HIV
1
Caregiver
1
Other disorders
Chapter H.5.1
Q1: In individuals with psychotic disorders (including schizophrenia), are antipsychotic drugs safe and effective?
Q3: In individuals with a first psychotic episode with full remission, how long should antipsychotic drug treatment be continued after remission in order to allow for the best outcomes?
Q5.SCOPING QUESTION: In individuals with psychotic disorders (including schizophrenia) who require long-term antipsychotic treatment, what is the safety and role of depot antipsychotic medication?
Q4: In individuals with long term and/or recurrent psychotic disorders (including schizophrenia), should individuals be maintained on pharmacotherapy indefinitely or withdrawn from treatment in order to allow for the best outcomes?
Second-generation antipsychotic medications for psychotic disorders (including schizophrenia)
recommended
Q14. SCOPING QUESTION: In adults with psychotic disorders (including schizophrenia), what is the comparative effectiveness and safety of second-generation antipsychotic medications?
Q2: In individuals with psychotic disorders (including schizophrenia), is the use of two or more antipsychotic medications concurrently more effective and safer than the use of one antipsychotic onl
...
Q6: In individuals with psychotic disorders (including schizophrenia) who require long term antipsychotic treatment, are anticholinergic medications more effective in preventing or reducing extrapyramidal side-effects and/or improving treatment adhe
...
Q7: In individuals with bipolar mania, are a) antipsychotics, b) mood stabilizers (lithium carbonate, valproate, and carbamazepine) effective and safe
Q8. SCOPING QUESTION: In people with bipolar disorders who require maintenance treatment, are a) antipsychotics or b) mood stabilizers (lithium, valproate or carbamazepine) effective and safe?
Q3: For behavioural and psychological symptoms in people with dementia, do following drugs, when compared to placebo/comparator, produce benefits/harm in the specified outcomes?
Accessed April 16, 2019
Fourth Edition
6th edition
Q15. SCOPING QUESTION: Is pharmacological intervention effective and safe for treatment of psychotic disorders in adolescents (including schizophrenia and bipolar disorder)?
Ethiopia National Essential Medicine List
recommended
6 edition
The Georgetown Undergraduate Journal of Health Services (2), 2012.
Other disorders Chapter H.1
This document gives you a step by step guide on running group sessions for people with schizophrenia and their caregivers in your community
